ATE509949T1 - Metastasisch spezifische peptide und ihre diagnostischen und therapeutischen anwendungen - Google Patents
Metastasisch spezifische peptide und ihre diagnostischen und therapeutischen anwendungenInfo
- Publication number
- ATE509949T1 ATE509949T1 AT07856330T AT07856330T ATE509949T1 AT E509949 T1 ATE509949 T1 AT E509949T1 AT 07856330 T AT07856330 T AT 07856330T AT 07856330 T AT07856330 T AT 07856330T AT E509949 T1 ATE509949 T1 AT E509949T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnostic
- metastasically
- therapeutic applications
- specific peptides
- peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000852A ITTO20060852A1 (it) | 2006-11-30 | 2006-11-30 | Peptidi metastasi-specifici e loro applicazioni diagnostiche e terapeutiche |
| PCT/EP2007/010428 WO2008064910A2 (en) | 2006-11-30 | 2007-11-30 | Metastasis-specific peptides and their diagnostic and therapeutic applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE509949T1 true ATE509949T1 (de) | 2011-06-15 |
Family
ID=39313019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07856330T ATE509949T1 (de) | 2006-11-30 | 2007-11-30 | Metastasisch spezifische peptide und ihre diagnostischen und therapeutischen anwendungen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8779092B2 (de) |
| EP (1) | EP2121742B1 (de) |
| JP (1) | JP2010510785A (de) |
| AT (1) | ATE509949T1 (de) |
| AU (1) | AU2007324808B2 (de) |
| CA (1) | CA2670532A1 (de) |
| ES (1) | ES2363044T3 (de) |
| IT (1) | ITTO20060852A1 (de) |
| WO (1) | WO2008064910A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2822302A1 (en) | 2006-02-13 | 2007-08-23 | Alethia Biotherapeutics Inc. | Methods of impairing osteoclast differentiation |
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| GB0708864D0 (en) * | 2007-05-08 | 2007-06-13 | Molmed Spa | Cytokine Conjugate |
| US8771642B2 (en) | 2008-07-31 | 2014-07-08 | Alma Mater Studiorum—Universita' di Bologna | Active particles for bio-analytical applications and methods for their preparation |
| EP2444101A1 (de) * | 2010-10-21 | 2012-04-25 | Universitätsklinikum Freiburg | Selektives Targeting der CD40L/Mac-1-Interaktion mit kleinen Peptidinhibitoren und seine Verwendung zur Behandlung von Entzündungen und Atherogenese |
| CU23950B1 (es) * | 2011-03-21 | 2013-10-29 | Ct De Ingeniería Genética Y Biotecnología | Péptidos cíclicos con actividad antineoplásica y antiangiogénica |
| ES2723885T3 (es) | 2012-07-19 | 2019-09-03 | Daiichi Sankyo Co Ltd | Anticuerpos anti-Siglec-15 |
| EP2703005A1 (de) | 2012-09-04 | 2014-03-05 | Università Degli Studi Di Torino | Hemmer des Alpha-6-Integrin/E-Cadherinkomplexes |
| WO2014037332A1 (en) | 2012-09-04 | 2014-03-13 | Università Degli Studi Di Torino | Inhibitors of alpha6 integrin/e-cadherin complex and their therapeutic and diagnostic use in cancer |
| JP6523965B2 (ja) * | 2012-12-28 | 2019-06-05 | コビオレス エヌヴイＣｏｂｉｏｒｅｓ Ｎｖ | 最小毒性プロドラッグ |
| AU2016255020B2 (en) * | 2015-04-27 | 2018-11-22 | Mackay Memorial Hospital | Short synthetic peptide for treatment and/or prophylaxis of autoimmune and inflammatory disorders |
| CN112724258A (zh) * | 2019-10-29 | 2021-04-30 | 深圳市第二人民医院 | 靶向杀死癌细胞的复合多肽分子及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877243A (en) * | 1997-05-05 | 1999-03-02 | Icet, Inc. | Encrustation and bacterial resistant coatings for medical applications |
| US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
| US6703491B1 (en) * | 1999-03-17 | 2004-03-09 | Exelixis, Inc. | Drosophila sequences |
| US7834146B2 (en) * | 2000-05-08 | 2010-11-16 | Monsanto Technology Llc | Recombinant polypeptides associated with plants |
| WO2003086284A2 (en) * | 2002-04-05 | 2003-10-23 | University Of Utah Research Foundation | Colon tumor specific binding peptides |
| WO2004093804A2 (en) * | 2003-04-18 | 2004-11-04 | Five Prime Therapeutics, Inc. | Human polypeptides encoded by polynucleotides and methods of their use |
| JP3944577B2 (ja) * | 2003-04-21 | 2007-07-11 | 独立行政法人産業技術総合研究所 | Ｒｈｏｄｏｃｏｃｃｕｓ属細菌における組換えタンパク質を生産する方法 |
| EP1765857A2 (de) * | 2004-07-02 | 2007-03-28 | Metanomics GmbH | Verfahren zur herstellung feiner chemikalien |
| EP2002036A4 (de) * | 2006-03-09 | 2010-01-27 | Univ Texas | Zusammensetzungen und verfahren in zusammenhang mit der profilierung mehrerer zelllinien auf peptidbindungsbasis |
| WO2007131300A1 (en) * | 2006-05-17 | 2007-11-22 | Dairy Australia Limited | Polypeptides and polynucleotides encoding the same |
-
2006
- 2006-11-30 IT IT000852A patent/ITTO20060852A1/it unknown
-
2007
- 2007-11-30 ES ES07856330T patent/ES2363044T3/es active Active
- 2007-11-30 CA CA002670532A patent/CA2670532A1/en not_active Abandoned
- 2007-11-30 WO PCT/EP2007/010428 patent/WO2008064910A2/en not_active Ceased
- 2007-11-30 EP EP07856330A patent/EP2121742B1/de not_active Not-in-force
- 2007-11-30 AU AU2007324808A patent/AU2007324808B2/en not_active Ceased
- 2007-11-30 AT AT07856330T patent/ATE509949T1/de not_active IP Right Cessation
- 2007-11-30 JP JP2009538647A patent/JP2010510785A/ja active Pending
- 2007-11-30 US US12/516,896 patent/US8779092B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010510785A (ja) | 2010-04-08 |
| US20100041614A1 (en) | 2010-02-18 |
| US20110294743A9 (en) | 2011-12-01 |
| ES2363044T3 (es) | 2011-07-19 |
| ITTO20060852A1 (it) | 2008-06-01 |
| WO2008064910A9 (en) | 2009-05-14 |
| AU2007324808B2 (en) | 2012-04-26 |
| WO2008064910A2 (en) | 2008-06-05 |
| AU2007324808A1 (en) | 2008-06-05 |
| EP2121742A2 (de) | 2009-11-25 |
| US8779092B2 (en) | 2014-07-15 |
| CA2670532A1 (en) | 2008-06-05 |
| WO2008064910A3 (en) | 2008-11-13 |
| US20100210563A2 (en) | 2010-08-19 |
| EP2121742B1 (de) | 2011-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008064910A3 (en) | Metastasis-specific peptides and their diagnostic and therapeutic applications | |
| CY1119892T1 (el) | Φορεις και αλληλουχιες για την αγωγη ασθενειων | |
| CY1118038T1 (el) | Λυοφιλισμενες φαρμακοτεχνικες μορφες θεραπευτικου πεπτισωματος | |
| CY1125550T1 (el) | Ορισμενες τριαζολοπυραζινες, συνθεσεις αυτων και μεθοδοι για τη χρηση αυτων | |
| MX2009008430A (es) | Anticuerpos anti-robo4 y sus usos. | |
| WO2007112940A3 (en) | Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same | |
| EA201171220A1 (ru) | Мутанты fgf21 и их применение | |
| WO2008140812A3 (en) | Compositions and methods comprising klk3, psca, or folh1 antigen | |
| ATE528989T1 (de) | Kristalline feste rasagilin-base | |
| EA201001883A1 (ru) | Мутанты fgf21 и их применение | |
| MY150226A (en) | Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and medicinal use | |
| GT201200189A (es) | Antagonistas de pcsk9 | |
| DE602006008625D1 (de) | Polymermicellen für die arzneistoffzufuhr | |
| BR112012011332A2 (pt) | agentes direcionados para gadd45beta | |
| CY1117328T1 (el) | Διαδικασια για την παρασκευη πολυσιαλικου οξεος υψηλης καθαρiοτητας | |
| EA201100268A1 (ru) | Вакцина | |
| MA32349B1 (fr) | Antagonistes de la voie hedgehog a base de phtalazines disubstituees | |
| EP2438090A4 (de) | Aminosäuresequenzen zur erhöhung der löslichkeit eines peptidkonjugats | |
| CY1114023T1 (el) | Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog | |
| ATE404225T1 (de) | Radiofluorierte peptide | |
| AR066395A1 (es) | Reovirus que tienen secuencias modificadas | |
| MX2009013682A (es) | Enlazador de fmoc polimerico hidrolizable. | |
| CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
| WO2009125409A3 (en) | Fatty acid amides and uses thereof | |
| BRPI0606687A2 (pt) | composições nutracêuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |